Clinical Trial Update: Enhancing Lung Health in Kids With Structural Lung Damage and Malformations: Azithromycin (AZI) for Airway Infection Prevention [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating azithromycin to prevent airway infections in children with structural lung damage; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atelectasis
• Bronchiectasis
• Bronchopulmonary Dysplasia
• Cystic Lung Disease
• Tracheomalacia
• Vascular Ring

Drugs mentioned

• Azithromycin (azithromycin)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Tracheomalacia, Bronchopulmonary Dysplasia (BPD) | Phase 3 | Status: NOT_YET_RECRUITING